Entera Bio
ENTX
27 hedge funds and large institutions have $19M invested in Entera Bio in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 6 closing their positions.
119% more capital invested
Capital invested by funds: $8.68M → $19M (+$10.3M)
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
4.6% more ownership
Funds ownership: 17.17% → 21.77% (+4.6%)
4% more funds holding
Funds holding: 26 → 27 (+1)
74% less call options, than puts
Call options by funds: $5K | Put options by funds: $19K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$3.03M |
| 2 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$921K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$329K |
| 4 |
HF
HRT Financial
New York
|
+$71.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$60.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$259K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$217K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$163K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$139K |
| 5 |
Renaissance Technologies
New York
|
-$131K |
ENTX Hedge Fund Activity: Q2 2026 in Review
27 of the 8,331 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q2 2026, worth a combined $19M — up 119% from $8.68M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ENTX positions and 6 closed out — a net gain of 1 holder — while 8 added to existing stakes and 6 trimmed.
The largest buyer was BVF Inc, opening a new position worth an estimated $3.03M. The largest seller was Citadel Advisors, cutting an estimated $259K.
- 27 institutional investors held Entera Bio (ENTX) as of Q2 2026, up from 26 in Q1 2026.
- Funds reported $19M of Entera Bio stock for Q2 2026, up 119% quarter-over-quarter.
- 7 funds opened new Entera Bio positions in Q2 2026 and 6 closed out, a net change of +1 holder.
- The largest Entera Bio buyer in Q2 2026 was BVF Inc, an estimated $3.03M added.
- The largest Entera Bio seller in Q2 2026 was Citadel Advisors, an estimated $259K sold.
Based on aggregated 13F filings for Q2 2026.